Diagnosis and Autonomic Testing
At a Glance
Pure autonomic failure is diagnosed by confirming a blood-pressure drop caused by autonomic nerve failure, then ruling out other conditions and central neurologic signs. Tilt-table, sweat, norepinephrine, and skin tests can support the diagnosis, but no single test proves it.
Diagnosing Pure Autonomic Failure (PAF) is a process of “connecting the dots” between your symptoms and the physical evidence of nerve failure. Because it is a rare condition, doctors use a series of specialized tests to confirm that your autonomic system is failing and to rule out other conditions like Parkinson’s disease or Multiple System Atrophy (MSA) [1][2].
A Diagnosis of Exclusion
It is important to know that PAF remains a clinical diagnosis. There is no single test that confirms the failure is completely “pure.” Instead, doctors must rule out many other causes of nerve failure. Your clinician will review your medications (as many blood pressure or prostate drugs cause orthostatic hypotension) and check for dehydration, anemia, diabetes, endocrine diseases, B12 deficiency, underlying heart conditions, and systemic diseases like amyloidosis or autoimmune autonomic ganglionopathy [1]. Only when these are ruled out and there are no central neurological signs (like tremors) does PAF become the likely diagnosis.
Confirming Neurogenic Orthostatic Hypotension (nOH)
The first step in diagnosing PAF is confirming that your blood pressure drops because of nerve failure, rather than simple dehydration or heart issues [3]. This is done by measuring your orthostatic vital signs—your blood pressure and heart rate while lying down and after standing for at least three minutes [4][5].
In PAF, the criteria for a diagnosis include:
- The Drop: A sustained fall in blood pressure of at least 20 mmHg (systolic) or 10 mmHg (diastolic) within 3 minutes of standing or being tilted upright [6][5].
- The Heart Rate: A hallmark of neurogenic (nerve-related) failure is that your heart rate does not rise enough to make up for the drop [7]. In a healthy person, the heart beats faster to push blood to the brain; in PAF, this response is blunted [8]. (Note that this response is only suggestive, as age, volume status, and medications like beta-blockers can alter it.)
Specialized Autonomic Testing
If basic vitals suggest a problem, you may undergo a formal autonomic reflex screen in a specialized lab [9]. These tests look at three different parts of your autonomic system:
- Tilt-Table Test: You are secured to a table that tilted upright (usually to 60 or 70 degrees) while your heart rate and blood pressure are monitored continuously [6]. This is more sensitive than standing vitals and can detect “delayed” drops that happen after several minutes [10].
- QSART (Quantitative Sudomotor Axon Reflex Test): Small capsules are placed on your skin (usually the arms and legs) to measure how your sweat glands respond to a mild electrical stimulation [9]. (“Sudomotor” refers to the nerves that control sweating). This helps determine if the nerves controlling your sweating are damaged.
- Thermoregulatory Sweat Test (TST): In this test, you are coated in a powder that changes color when it gets wet and placed in a warm room [11]. This creates a “map” of where you can and cannot sweat, helping doctors see the extent of your nerve involvement [12].
The Role of Norepinephrine
Your body uses a chemical called norepinephrine as a messenger to maintain blood pressure. Measuring the levels of this chemical in your blood is one of the ways doctors distinguish PAF from other conditions, though it is supportive rather than purely diagnostic [13].
- In PAF: Because the peripheral (postganglionic, or outer) nerves are damaged, they release less norepinephrine. This often leads to very low supine plasma norepinephrine levels (measured while you are lying down) [13][14].
- In MSA: Because MSA primarily affects the brain rather than the peripheral nerves, norepinephrine levels in the blood are often normal or only slightly reduced [14][15].
Important Caution: Results depend heavily on posture, collection conditions, age, and medications. MSA values can overlap with PAF values. Do not stop any medications for testing unless explicitly instructed by your clinician.
Alpha-Synuclein Skin Biopsies
A newer tool in the diagnostic toolkit is a skin biopsy to look for phosphorylated alpha-synuclein—the misfolded protein that causes PAF [16].
A small punch biopsy (about the size of a pencil eraser) is taken from three or four spots, such as the ankle, thigh, and neck [17][18]. If the biopsy shows this protein within your small nerve fibers, it supports that you have a “synucleinopathy” (a disease caused by this protein) [16].
While a positive biopsy is very helpful, its interpretation is still center- and method-dependent. It does not distinguish between PAF, Parkinson’s, or MSA on its own, as all three involve this protein [17][19]. Instead, your doctor will look at the distribution of the protein and your clinical symptoms [20][17]. Areas of nerve loss in the heart (detected by cardiac MIBG imaging) can also support a pattern of cardiac sympathetic denervation in PAF over MSA, but this imaging is affected by cardiac disease, diabetes, and medications, and requires clinical correlation [19][21].
Common questions in this guide
How is pure autonomic failure diagnosed?
What blood pressure and heart-rate changes point to neurogenic orthostatic hypotension?
What tests are included in an autonomic reflex screen?
What does a low norepinephrine level mean in pure autonomic failure?
Can a skin biopsy confirm pure autonomic failure?
Could cardiac MIBG imaging help distinguish pure autonomic failure from Multiple System Atrophy?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Pure autonomic failure.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What was my heart rate response compared to my blood pressure drop during the tilt-table test, and does it confirm neurogenic orthostatic hypotension?
- 2.What was my supine plasma norepinephrine level, and how does it help distinguish my condition from Multiple System Atrophy?
- 3.Do my sweat test results (QSART or TST) show a pattern that is more characteristic of a peripheral or central nervous system issue?
- 4.If we do a skin biopsy, how will you use the results to help determine the best long-term management plan for me?
- 5.Are there any other tests, like cardiac MIBG imaging, that would help clarify my diagnosis?
References
References (21)
- 1
Pure Autonomic Failure-A Localized Alpha Synucleinopathy with a Potential for Conversion to More Extensive Alpha Synucleinopathies.
Bhattacharjee S, Alsukhni RA
Annals of Indian Academy of Neurology 2022; (25(3)):340-346 doi:10.4103/aian.aian_1078_21.
PMID: 35936586 - 2
Pure Autonomic Failure.
Thaisetthawatkul P
Current neurology and neuroscience reports 2016; (16(8)):74 doi:10.1007/s11910-016-0673-2.
PMID: 27338613 - 3
Orthostatic Hypotension in Parkinson Disease.
Palma JA, Kaufmann H
Clinics in geriatric medicine 2020; (36(1)):53-67 doi:10.1016/j.cger.2019.09.002.
PMID: 31733702 - 4
Droxidopa for Hypotension of Different Etiologies: Two Case Reports.
Oommen J, Chen J, Wang S, et al.
P & T : a peer-reviewed journal for formulary management 2019; (44(3)):125-144.
PMID: 30828233 - 5
Persistent unexplained chest pain and dyspnea in a patient with coronary artery disease: a case report.
Mobarek SK
BMC cardiovascular disorders 2020; (20(1)):54 doi:10.1186/s12872-020-01348-w.
PMID: 32019498 - 6
Management of Supine Hypertension Complicating Neurogenic Orthostatic Hypotension.
Baker J, Kimpinski K
CNS drugs 2017; (31(8)):653-663 doi:10.1007/s40263-017-0453-9.
PMID: 28702747 - 7
Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies.
Norcliffe-Kaufmann L, Kaufmann H, Palma JA, et al.
Annals of neurology 2018; (83(3)):522-531 doi:10.1002/ana.25170.
PMID: 29405350 - 8
Role of nurses and nurse practitioners in the recognition, diagnosis, and management of neurogenic orthostatic hypotension: a narrative review.
Biswas D, Karabin B, Turner D
International journal of general medicine 2019; (12()):173-184 doi:10.2147/IJGM.S170655.
PMID: 31118743 - 9
Electrodiagnostic assessment of the autonomic nervous system: A consensus statement endorsed by the American Autonomic Society, American Academy of Neurology, and the International Federation of Clinical Neurophysiology.
Cheshire WP, Freeman R, Gibbons CH, et al.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2021; (132(2)):666-682 doi:10.1016/j.clinph.2020.11.024.
PMID: 33419664 - 10
Use of Valsalva Maneuver to Detect Late-Onset Delayed Orthostatic Hypotension.
Park JW, Okamoto LE, Kim SH, et al.
Hypertension (Dallas, Tex. : 1979) 2023; (80(4)):792-801 doi:10.1161/HYPERTENSIONAHA.122.20098.
PMID: 36695176 - 11
A Case of Pure Autonomic Failure Initially Presenting with Hemihypohidrosis: Twelve-Year Follow-Up.
Saito H
Case reports in neurology 2022; (14(1)):202-207 doi:10.1159/000523851.
PMID: 35702060 - 12
Pure autonomic failure.
Kabir MA, Chelimsky TC
Handbook of clinical neurology 2019; (161()):413-422 doi:10.1016/B978-0-444-64142-7.00064-3.
PMID: 31307617 - 13
Pharmacologic treatment of orthostatic hypotension.
Park JW, Okamoto LE, Shibao CA, Biaggioni I
Autonomic neuroscience : basic & clinical 2020; (229()):102721 doi:10.1016/j.autneu.2020.102721.
PMID: 32979782 - 14
Neurogenic orthostatic hypotension: roles of norepinephrine deficiency in its causes, its treatment, and future research directions.
Loavenbruck A, Sandroni P
Current medical research and opinion 2015; (31(11)):2095-104 doi:10.1185/03007995.2015.1087988.
PMID: 26373628 - 15
Distinct Sympathoneural and Cardiovagal Domains of Arterial Baroreflex Function in Autonomic Synucleinopathies.
Goldstein DS
Research square 2026; doi:10.21203/rs.3.rs-9248308/v1.
PMID: 42183382 - 16
Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies.
Gibbons CH, Levine T, Adler C, et al.
JAMA 2024; (331(15)):1298-1306 doi:10.1001/jama.2024.0792.
PMID: 38506839 - 17
Skin nerve misfolded α-synuclein in pure autonomic failure and Parkinson disease.
Donadio V, Incensi A, Piccinini C, et al.
Annals of neurology 2016; (79(2)):306-16 doi:10.1002/ana.24567.
PMID: 26606657 - 18
Standardized protocol to detect phosphorylated α-synuclein in skin biopsies: recommendations from an expert panel.
Donadio V, Gibbons C, Delprete C, et al.
Molecular neurodegeneration 2026; (21(1)).
PMID: 42351184 - 19
Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.
Giannoccaro MP, Donadio V, Giannini G, et al.
Parkinsonism & related disorders 2020; (81()):48-53 doi:10.1016/j.parkreldis.2020.10.016.
PMID: 33049589 - 20
Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease.
Gibbons C, Wang N, Rajan S, et al.
Neurology 2023; (100(15)):e1529-e1539 doi:10.1212/WNL.0000000000206772.
PMID: 36657992 - 21
Clinical utility of synuclein skin biopsy in the diagnosis and evaluation of synucleinopathies.
Isaacson JR, Freeman R, Gibbons CH
Frontiers in neurology 2024; (15()):1510796 doi:10.3389/fneur.2024.1510796.
PMID: 39744104
This page explains how clinicians evaluate suspected pure autonomic failure for educational purposes; it does not replace medical advice. Ask your neurologist how your test results fit your symptoms and other conditions.